Dimitrios (Dimitri) Makrakis
@DMakrakisMD
Followers
612
Following
1K
Media
5
Statuses
308
MD, PGY-3 @jacobihosp @einsteinmed - GU Onc Research Fellow @UoWashington from @UOC_gr 🇬🇷🇺🇲
New York, USA
Joined September 2020
Honored to discuss with @Daniel_J_George on CN role in ICI-treated mRCC; fantastic mentorship of @PavlosMsaouel & JoseAKaram and the superb @SM_Esagian Watch out for this rising ⭐️ applying to #hemonc ! @PGrivasMDPhD @montypal @neerajaiims @koshkin85 @PBarataMD @shilpaonc.
The role of nephrectomy with immunotherapy in metastatic #RenalCellCarcinoma. @DMakrakisMD @JacobiHosp joins @Daniel_J_George @DukeCancer to discuss gaps in understanding post-CARMENA, focusing on outcomes in the era of immune checkpoint inhibitors >
4
8
41
RT @PGrivasMDPhD: Join @CParkMD & me on Dec 13 in Seattle for a fantastic Master Lectures series with stellar speakers, interactions, fun!….
0
10
0
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
413
690
3K
RT @urotoday: ctDNA in #BladderCancer: Prognostic value and ongoing clinical trials. @DrRosenbergMSK @MSKCancerCenter & @PGrivasMDPhD @fred….
0
4
0
RT @EurUrolFocus: New editor‘s choice by @MalteRieken:. Deferred cytoreductive nephrectomy is superior to upfront nephrectomy. https://t.c….
0
6
0
RT @PGrivasMDPhD: So honored to receive this prestigious award by @eaonc kudos to all investigators/staff who work hard to conduct trials….
0
22
0
RT @IA_Ziogas: To all IMGs out there, the path is long but very much possible and rewarding. Many will say you can’t do it, we’re here say….
0
19
0
Fantastic and informative session, thank you @PGrivasMDPhD @drenriquegrande and of course @OncBrothers !!.
Excited to discuss new updates in GU cancers (bladder, prostate, RCC) & clinical implications with @OncBrothers @drenriquegrande @SignifyMD @ASCO #ASCO25 @nataliagandur @DMakrakisMD @GIcancerDoc @NarjustFlorezMD @NVijayvergiaMD @fredhutch @HsiehLab @mshadman @RahulBanerjeeMD
0
5
13
Such a well deserved recognition for @PGrivasMDPhD who has been incredibly dedicated to patient care and research! Fantastic role model! Mentees are very grateful @SM_Esagian @pdzavras @DRBakaloudiMD @panos_zb.
Honored/humbled for kind award by @eaonc Am so excited to work in this amazing community of stellar leaders, staff, investigators aiming to inform practice & help patients! .@fredhutch @HutchPresident @nicoleflemingmd @HsiehLab @jrgralow @CliffordHudis @lynn_schuchter @NaomiHaas5
0
2
11
RT @jmcchiefs: Our annual talent show night was a huge success! Amazing performances by our talented residents and tons of laughs along th….
0
6
0
RT @urotoday: Investigating PARP expression as a biomarker for targeted therapy in #ProstateCancer. @EAntonarakis @UMNCancer sits down with….
0
2
0
RT @PGrivasMDPhD: Join our GU dream team @fredhutch @UWMedicine dedicated to exceptional patient care, innovative research, education, outr….
0
10
0
RT @PGrivasMDPhD: Honored to serve in my new role as co-chair of @eaonc GU committee working with amazing @NaomiHaas5 & stellar colleagues….
0
19
0
RT @PavlosMsaouel: 1/5 Sharing our @CCR_AACR work establishing serum CA-125 as a biomarker for #RenalMedullaryCarcinoma. This is now the fi….
0
63
0
Excited to see our work with ⭐️@SM_Esagian @PavlosMsaouel being featured in #ascoGU25 among many others! Interesting trend of declining CN rates even before CARMENA. @PGrivasMDPhD @montypal @neerajaiims @arkhaki @Daniel_J_George @AndrewGutwein @jmcchiefs.
Excited to present our findings on cytoreductive nephrectomy utilization trends at @ASCO #GU25! Stop by Poster Board D15 to explore the impact of newer mRCC systemic therapies and socioeconomic determinants on current practice patterns! @PavlosMsaouel @DMakrakisMD
0
5
24
Very well deserved!!.
Truly honored to receive this recognition from @ConquerCancerFd! Excited to present our findings on cytoreductive nephrectomy utilization trends and disparities at @ASCO #GU25. Grateful to my mentors and collaborators @PavlosMsaouel @DMakrakisMD.
0
0
3
RT @SM_Esagian: Truly honored to receive this recognition from @ConquerCancerFd! Excited to present our findings on cytoreductive nephrecto….
0
5
0
RT @shilpaonc: @UrologieParis @PGrivasMDPhD @ClevelandClinic @karima_oualla @NawfelMellas Agree 💯Amazing discussion by @PGrivasMDPhD discus….
0
3
0
Out now: ICI efficacy in FGFR, MTAP, ERBB2 alterations 🧬 in aUC. Very happy for more research with this fantastic team @rafee_talukder @DRBakaloudiMD @arkhaki @neerajaiims @koshkin85 @LDiamantMD92 @PBarataMD @shilpaonc @PGrivasMDPhD and more!.
Excited for 1 more paper from our multi-center database on genomic biomarkers & response/survival with anti-PD1/L1 in pts with advanced urothelial Ca!Kudos to super mentees @rafee_talukder(1st author) @DRBakaloudiMD @DMakrakisMD @koshkin85 @RubenRaychaud .
0
2
16
RT @PGrivasMDPhD: So proud of amazing mentee @SM_Esagian with phenomenal match @MDAndersonNews he will work with stellar colleagues @Pavlos….
0
9
0
RT @SM_Esagian: Absolutely thrilled to share that I’ve matched at MD Anderson for my hematology/oncology fellowship! Immensely grateful to….
0
20
0